| Literature DB >> 23110375 |
Marc Albersmeyer1, Robert Hilge, Angelika Schröttle, Max Weiss, Thomas Sitter, Volker Vielhauer.
Abstract
BACKGROUND: Oxalosis is a metabolic disorder characterized by deposition of oxalate crystals in various organs including the kidney. Whereas primary forms result from genetic defects in oxalate metabolism, secondary forms of oxalosis can result from excessive intestinal oxalate absorption or increased endogenous production, e.g. after intoxication with ethylene glycol. CASEEntities:
Mesh:
Substances:
Year: 2012 PMID: 23110375 PMCID: PMC3504561 DOI: 10.1186/1471-2369-13-141
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Laboratory data at presentation
| Leukocytes (G/l) | 4.0−11.0 | 7.9 |
| Erythrocytes (T/) | 4.20−5.10 | |
| Hemoglobin (g/dl) | 12.0−16.0 | |
| Hematocrit (%) | 36.0−46.00 | |
| Mean corpuscular volume (fl) | 78.0−98.0 | 98 |
| Mean corpuscular hemoglobin (pg) | 26.0−32.0 | |
| Mean corpuscular hemoglobin concentration (g/dl) | 32.0−36.0 | 34.6 |
| Platelet count (G/l) | 150−400 | 351 |
| | | |
| Sodium (mmol/l) | 135−145 | 138 |
| Potassium (mmol/l) | 3.5−5.0 | |
| Glucose (mg/dl) | 60−100 | |
| Urea nitrogen (mg/dl) | 7−23 | |
| Creatinine (mg/dl) | 0.5−1.0 | |
| Estimated glomerular filtration rate (MDRD) (ml/min/1.73 m2) | ≥60.0 | |
| Calcium (mg/dl) | 2.15−2.50 | |
| Calcium (protein-corrected) (mmol/l) | 2.15−2.50 | |
| Phosphorus (mg/dl) | 2.5−4.8 | |
| C−reactive protein (mg/dl) | <0.50 | 0.18 |
| Total protein (g/dl) | 6.0−8.5 | 7.6 |
| Carbone dioxide (mmol/l) | 23.0−29.0 | |
| Intact parathyroid hormone (pg/ml) | 15−65 | |
| | | |
| | | |
| White cells (per μl) | 0-10 | 0 |
| Nitrites | neg. | neg. |
| pH | 5.0−6.0 | 5.5 |
| Protein (mg/dl) | neg. | |
| Glucose (mg/dl) | neg. | |
| Ketones (mg/dl) | neg. | neg. |
| Urobilinogen (mg/dl) | <1.0 | 0.2 |
| Bilirubin | neg. | neg. |
| Blood (per μl) | 0-5 | |
| Specific weight (g/l) | 1005−1030 | 1025 |
| | | |
| White cells (per high-power field) | <10 | 1-3 |
| Red cells (per high-power field) | <2 | 1-3 |
| Epithelial cells (per high-power field) | - | |
| Hyaline casts (per low-power field) | - | |
| Granulated casts (per low-power field) | - | |
| Cellular casts (per low-power field) | - | |
| BUN (urine) (mg/dl) | 700.0−1213.0 | 492 |
| Creatinine (urine) (mg/dl) | 30.0−220.0 | 79.2 |
| Protein (urine) (mg/dl) | <15.0 | |
| Protein/creatinine ratio (mg/g) | <100.0 | |
| Albumin (urine) (mg/dl) | <2.0 | |
| Albumin/creatinine ratio (mg/g)) | <20.0 | |
| α1−Microglobulin (urine) (mg/l) | <12.0 | |
| α1−Microglobulin/creatinine (mg/g) | <14.0 | |
| Monoclonal immunoglobulins | | negative |
| Complement C3 (mg/dl) | 90.0−180.0 | 115 |
| Complement C4 (mg/dl) | 10.0−40.0 | 31.7 |
| Antinuclear antibodies (ANA) | | |
| Antineutrophil cytoplasmic antibodies (ANCA) | | negative |
| Anti basal membrane antibodies (ELISA) (IU/ml) | <20.000 | <20.0 |
Values outside the reference range are shown in bold print.
Figure 1(A) Oxalate crystals (arrows) within the renal tubular lumen in a hematoxylin eosin-stained section (original magnification x200) and (B) under polarisation light microscopy (original magnification x100). Adjacent glomeruli show mild diabetic mesangial sclerosis.
24 hour urine analysis
| Oxalate (mmol/1,73 m2/d) | <0.5 | 0.39 |
| Glycolate (mmol/1,73 m2/d) | <0.5 | 0.34 |
| Citrate (mmol/d) | 0.3 – 7.4 | 2.25 |
| Calcium (mg/d) | <250 | 176 |